July 23 (Reuters) - Redwood Pharma AB REDWPH.TE :
* NEW PATENT FOR THE USE OF ESTROGENS IN THE TREATMENT OF
DED TO
BE ISSUED IN THE US
* US PATENT AND TRADEMARK OFFICE HAS ISSUED A NOTICE OF
ALLOWANCE
INDICATING THAT A NEW PATENT WILL BE GRANTED TO REDWOOD PHARMA
REGARDING USE OF ESTROGENS IN TREATMENT OF DRY EYE DISEASE
* THIS NEW PATENT WILL COMPLEMENT EXISTING PATENT PROTECTION
OF
RP101 INCLUDING USE OF INTELLIGEL IN US.
Source text for Eikon: ID:nWkr5lPGqt
Further company coverage: REDWPH.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))